Company | Palantir Technologies Inc. |
Ticker | PLTR (NASDAQ) |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Earnings Date | August 3, 2026 — After Market Close (5:00 PM ET Webcast) |
Prepared | August 2, 2026 |
Primary Valuation Metric | NTM EV/Sales (~29x) | NTM P/E (~65x) |
Key Takeaway: The setup is a high bar with meaningful upside risk — U.S. Commercial revenue is the single biggest swing factor, and consensus at $718M implies ~135% YoY growth against management's own 120%+ full-year guide, leaving room for another beat-and-raise if enterprise AI demand continues to accelerate.
Palantir heads into Q2 2026 earnings on August 3 with the Street expecting revenue of ~$1.81B (+80% YoY), adjusted operating income of ~$1.08B (60% margin), and adjusted EPS of ~$0.35 (+117% YoY) — a high bar by any historical standard, yet one the company has consistently cleared and raised. Management's posture coming out of Q1 was the most confident in the company's public history: the largest-ever full-year guidance raise (+10 points to 71% growth), U.S. Commercial guided to 120%+ growth, and CEO Alex Karp framing demand as "once in a lifetime" — a tone that has not softened in the intervening quarter. Estimate revisions have tracked guidance closely, with consensus revenue for Q2 moving from $1.813B (post-Q1 baseline) to $1.814B today — essentially flat, suggesting the Street has already absorbed the guidance raise and is not pricing in incremental upside. The stock has given back ~16% since the Q1 print (May 4 close of $146.03 vs. ~$123 today), driven almost entirely by multiple compression (NTM EV/Sales contracted from ~57x to ~29x over six months) rather than estimate cuts, creating a more attractive entry point but also signaling that the market is demanding proof of sustained execution at these growth rates. The key wildcard is whether the U.S. Government segment can sustain its Q1 acceleration (+84% YoY) alongside continued U.S. Commercial strength — any evidence of a customer program reclassification (as occurred in Q1, which understated commercial growth) or a new large government award could be the catalyst that re-rates the stock higher.
Key Takeaway: Consensus is a high bar on an absolute basis, but Palantir has beaten every quarter for 11 consecutive quarters; U.S. Commercial revenue is the bigger swing factor — any acceleration above the guided 120%+ growth rate would be the most meaningful upside signal.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Q2 2026 Guidance | Consensus vs. Guidance |
Total Revenue ($M) | $1,632.6 | $1,003.7 | $1,814.3 | +80.8% YoY | $1,797–$1,801M (mid: $1,799M) | +0.9% above mid |
U.S. Commercial Revenue ($M) | $595.0 | $306.0 | $717.9 | +134.6% YoY | >$3,224M FY (120%+ growth) | Tracking above FY run-rate |
Adj. Operating Income ($M) | $983.5 | $464.4 | $1,082.4 | +133.0% YoY | $1,063–$1,067M (mid: $1,065M) | +1.6% above mid |
Adj. Operating Margin (%) | 60.2% | 46.3% | ~59.7% | +1,340 bps YoY | Implied ~59.2% at guidance mid | ~+50 bps above guidance |
Adj. EPS — Diluted ($) | $0.33 | $0.16 | $0.351 | +119.4% YoY | N/A — not guided explicitly | N/A |
Free Cash Flow ($M) | $891.8 | $531.6 | $1,079.3 | +103.0% YoY | FY: $4.2–$4.4B | Tracking within FY range |
Quarter | Reported ($M) | Consensus ($M) | Surprise % | Result |
Q2 2024 | $678.1 | N/A — not in VA | N/A | N/A |
Q3 2024 | $725.5 | $704.9 | +2.9% | ✅ Beat |
Q4 2024 | $827.5 | $776.2 | +6.6% | ✅ Beat |
Q1 2025 | $883.9 | $862.3 | +2.5% | ✅ Beat |
Q2 2025 | $1,003.7 | $939.5 | +6.8% | ✅ Beat |
Q3 2025 | $1,181.1 | $1,093.1 | +8.1% | ✅ Beat |
Q4 2025 | $1,406.8 | $1,340.5 | +4.9% | ✅ Beat |
Q1 2026 | $1,632.6 | $1,539.2 | +6.1% | ✅ Beat |
Quarter | Reported ($) | Consensus ($) | Surprise % | Result |
Q3 2024 | $0.10 | $0.089 | +12.2% | ✅ Beat |
Q4 2024 | $0.14 | $0.111 | +26.1% | ✅ Beat |
Q1 2025 | $0.13 | $0.128 | +1.6% | ✅ Beat |
Q2 2025 | $0.16 | $0.137 | +16.8% | ✅ Beat |
Q3 2025 | $0.21 | $0.168 | +25.0% | ✅ Beat |
Q4 2025 | $0.25 | $0.230 | +8.7% | ✅ Beat |
Q1 2026 | $0.33 | $0.280 | +17.9% | ✅ Beat |
Pattern: PLTR has beaten revenue consensus in every quarter shown, with surprise magnitude accelerating from ~3% in Q3 2024 to ~6-8% in recent quarters. EPS beats have been even more consistent and larger in magnitude, averaging ~15% above consensus over the last 7 quarters, reflecting ongoing margin expansion that the Street has consistently underestimated.
Key Takeaway: Guidance has not been formally revised since the Q1 2026 earnings call on May 4, 2026 — the baseline remains the largest-ever full-year raise in company history; tone has remained highly confident through AIPCon 10 (June 4) and the Nvidia partnership announcement (June 29), with no cautionary signals.
Metric | Initial Guidance (Q1 2026 Earnings Call, May 4, 2026) | Revised Guidance | Current Consensus | Note |
Q2 2026 Revenue | $1,797M – $1,801M | — | $1,814M | No post-earnings revision; consensus +0.9% above guidance midpoint |
Q2 2026 Adj. Operating Income | $1,063M – $1,067M | — | $1,082M | No post-earnings revision; consensus +1.6% above guidance midpoint |
FY 2026 Revenue | $7,650M – $7,662M (71% YoY growth) | — | $7,740M | No post-earnings revision; consensus +1.1% above guidance midpoint; largest-ever full-year raise at Q1 print (+10 pts) |
FY 2026 U.S. Commercial Revenue | >$3,224M (120%+ YoY growth) | — | $3,221M | Consensus essentially at guidance floor; upside if Q2 accelerates above Q1’s 133% YoY |
FY 2026 Adj. Operating Income | $4,440M – $4,452M | — | $4,566M | Consensus +2.6% above guidance midpoint; Street pricing in continued margin outperformance |
FY 2026 Adj. Free Cash Flow | $4,200M – $4,400M | — | $4,236M | Consensus at low end of guidance range; FCF has historically exceeded operating income margin |
FY 2026 Rule of 40 Score | 129% (full-year target) | — | N/A — not tracked in VA | Q1 2026 actual was 145%; full-year target implies deceleration from Q1 peak |
Key Takeaway: Estimates have been essentially flat since the Q1 print — the Street absorbed the guidance raise immediately and has not revised further, suggesting no incremental cushion or risk has been built in; the gap between consensus and guidance midpoint is narrow (+0.9% on Q2 revenue), meaning any beat must come from execution above guidance rather than estimate drift.
KPI (Period) | Estimate ~5 Days Post Q1 Print (May 11, 2026) | Current Consensus (Aug 2, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Total Revenue — Q2 2026 | $1,813.1M | $1,814.3M | +0.1% | $1,797–$1,801M | Unchanged | — | +0.9% above mid |
Total Revenue — FY 2026 | $7,732.5M | $7,739.7M | +0.1% | $7,650–$7,662M | Unchanged | — | +1.1% above mid |
U.S. Commercial Revenue — Q2 2026 | $717.7M | $717.9M | +0.0% | >$3,224M FY (120%+ growth) | Unchanged | — | Tracking at guidance floor |
U.S. Commercial Revenue — FY 2026 | $3,206.5M | $3,221.1M | +0.5% | >$3,224M | Unchanged | — | ~Flat vs. guidance floor |
Adj. Operating Income — Q2 2026 | $1,076.8M | $1,082.4M | +0.5% | $1,063–$1,067M | Unchanged | — | +1.6% above mid |
Adj. Operating Income — FY 2026 | $4,537.5M | $4,565.7M | +0.6% | $4,440–$4,452M | Unchanged | — | +2.6% above mid |
Adj. EPS — Q2 2026 | $0.348 | $0.351 | +0.9% | N/A | N/A | — | N/A |
Adj. EPS — FY 2026 | $1.478 | $1.492 | +0.9% | N/A | N/A | — | N/A |
Estimates have barely moved since the Q1 print — the Street locked in the guidance raise immediately and has not revised further in either direction. The narrow gap between consensus and guidance midpoint (~+0.9% on revenue) means the bar is effectively set at guidance, and any beat must come from genuine execution above the company's own targets rather than estimate drift. The FY 2026 U.S. Commercial consensus of $3.22B sits just below the guidance floor of $3.224B, implying the Street is not yet pricing in upside to the 120%+ growth target.
Key Takeaway: PLTR has underperformed both XLK and the S&P 500 since the Q1 print, declining ~16% vs. XLK +8% and SPY +4% — the underperformance is driven almost entirely by multiple compression (NTM EV/Sales contracted from ~57x to ~29x over six months), not estimate cuts, suggesting the stock is pricing in a lower growth premium rather than deteriorating fundamentals.
Since the Q1 2026 earnings close on May 4, 2026 ($146.03), PLTR has declined to $123.09 as of July 31, 2026 (−15.7%), while XLK gained +8.2% ($162.05 → $175.38) and SPY gained +4.0% ($718.01 → $747.07). The stock peaked at $160.65 on June 1 before a sharp 33% drawdown to a trough of $107.27 on June 25, driven by sector rotation out of software, NHS contract review concerns, and France’s stated intent to sever ties with Palantir. The stock partially recovered on the Nvidia partnership announcement (June 29, +3.3%) and has since stabilized in the $120–$135 range. Key events marked on the chart below: AIPCon 10 (June 4), NHS contract review news (June 9), Nvidia partnership (June 29), GNP Seguros Mexico deal (July 7), and the July 28 French intelligence pivot news (−10.4% single-day drop).
Stock performance decomposition: Over the past 6 months, PLTR is down ~19% while NTM EV/EBITDA contracted ~58% (from ~114x to ~48x) and NTM EV/Sales contracted ~49% (from ~57x to ~29x). This confirms the decline is a valuation de-rating, not an earnings story — estimates have actually risen slightly since Q1. The stock’s current NTM P/E of ~65x and EV/Sales of ~29x represent a significant compression from peak multiples, but remain well above software sector averages, leaving the stock vulnerable to any execution miss.
Date | PLTR Price | PLTR Indexed (Base=100) | XLK Indexed | SPY Indexed |
May 4, 2026 (Q1 Earnings) | $146.03 | 100.0 | 100.0 | 100.0 |
Jun 1, 2026 (Peak) | $160.65 | 110.0 | 120.8 | 105.6 |
Jun 9, 2026 (NHS Review News) | $132.07 | 90.4 | 111.6 | 102.7 |
Jun 25, 2026 (Trough) | $107.27 | 73.5 | 113.8 | 102.3 |
Jun 29, 2026 (Nvidia Deal) | $112.93 | 77.3 | 111.8 | 101.5 |
Jul 7, 2026 (GNP Seguros Deal) | $134.37 | 92.0 | 110.6 | 104.1 |
Jul 28, 2026 (France Intel Pivot) | $123.53 | 84.6 | 105.6 | 103.2 |
Jul 31, 2026 (Latest) | $123.09 | 84.3 | 108.2 | 104.0 |
Key Takeaway: The most important development since Q1 earnings is the Nvidia partnership (June 29) — it validates PLTR’s U.S. government AI positioning and snapped a brutal 7-session losing streak; the NHS contract review and France’s pivot away from U.S. tech are the primary overhangs heading into the print.
Key Takeaway: Peer commentary from Oracle (Q4 FY26 call, June 10), ServiceNow (Q2 2026 call, July 22), CrowdStrike (Q1 FY27 call, June 3), and Adobe (Q2 FY26 call, June 11) all point to accelerating enterprise AI demand, no deal cycle elongation, and expanding customer budgets for AI platforms — a uniformly positive read-through for PLTR’s Q2 2026 U.S. Commercial and Government revenue.
Note on methodology: Only commentary about each peer’s then-current or future reporting quarter is included below. Retrospective prior-quarter results discussion has been excluded. All peers reported within the last 60 days (June 3 – July 22, 2026).
Read-Through Direction: POSITIVE
Relevance to PLTR: ServiceNow is the closest enterprise AI platform peer to Palantir in terms of agentic AI deployment, government exposure, and platform-native governance. NOW’s Q2 commentary about its then-current quarter (Q3 2026 guidance) and forward demand signals are directly applicable to PLTR’s Q2 2026 setup.
Read-Through Direction: POSITIVE
Relevance to PLTR: Oracle’s Q4 FY26 call (reporting its quarter ended May 31, 2026) provided forward guidance for Q1 FY27 and commentary on enterprise AI demand that overlaps with PLTR’s Q2 2026 reporting period. Oracle’s enterprise customer base and government exposure make it a meaningful read-through for PLTR’s commercial and government segments.
Read-Through Direction: POSITIVE
Relevance to PLTR: CrowdStrike’s Q1 FY27 call (reporting its quarter ended April 30, 2026) provided guidance for Q2 FY27 and full-year FY27, with extensive commentary on enterprise AI adoption and cybersecurity demand that directly overlaps with PLTR’s Apollo cybersecurity platform and AIP governance narrative.
Read-Through Direction: MIXED
Relevance to PLTR: Adobe’s Q2 FY26 call (reporting its quarter ended May 30, 2026) provided guidance for Q3 FY26 and commentary on enterprise AI demand and customer budget dynamics. Adobe is less directly comparable to PLTR than NOW or CRWD, but its enterprise AI commentary and customer budget observations are relevant to the broader demand environment.
Peer | Call Date | Direction | Key Signal for PLTR |
ServiceNow (NOW) | Jul 22, 2026 | POSITIVE | Agentic AI at inflection; U.S. federal demand strongest ever; no deal cycle elongation; guidance raised |
Oracle (ORCL) | Jun 10, 2026 | POSITIVE | Customers past AI experimentation; demand exceeds supply; deal delays resolved; record RPO |
CrowdStrike (CRWD) | Jun 3, 2026 | POSITIVE | AI security demand unprecedented; customers want to deploy AI faster; FY27 guidance raised 520 bps |
Adobe (ADBE) | Jun 11, 2026 | MIXED | AI demand strong but freemium strategy sacrifices near-term revenue; macro stable |
Key Takeaway: All insider transactions since the Q1 print are 10b5-1 planned sales — no discretionary selling or open-market buying; the pattern is consistent with pre-scheduled liquidation programs and does not signal any change in insider conviction.
Name | Title | Transaction Type | Shares | Approx. Value | Transaction Date | Note |
Sankar Shyam | CTO / See Remarks | 10b5-1 Planned Sale | 185,000 | ~$23.8M (est. at ~$129) | Jul 2, 2026 | Pre-scheduled 10b5-1 plan; 150K indirect + 35K direct; not discretionary |
Moore Alexander D. | Director | 10b5-1 Planned Sale | 16,000 | ~$2.1M (est. at ~$134) | Jul 15, 2026 | Recurring monthly 10b5-1 sale; third consecutive month at same share count |
Moore Alexander D. | Director | 10b5-1 Planned Sale | 16,000 | ~$2.1M (est. at ~$131) | Jun 15, 2026 | Recurring monthly 10b5-1 sale; consistent with prior months |
Stat Lauren Elaina Friedman | Director | 10b5-1 Planned Sale | 1,667 | ~$0.2M (est. at ~$137) | May 29, 2026 | Small pre-scheduled sale; not discretionary |
Buckley Jeffrey | See Remarks | 10b5-1 Planned Sale | 1,712 | ~$0.2M (est. at ~$137) | May 20, 2026 | Pre-scheduled 10b5-1 plan; not discretionary |
Glazer David A. | CFO / See Remarks | 10b5-1 Planned Sale | 17,128 | ~$2.3M (est. at ~$137) | May 20, 2026 | Pre-scheduled 10b5-1 plan; not discretionary |
Taylor Ryan D. | President / See Remarks | 10b5-1 Planned Sale | 19,662 | ~$2.7M (est. at ~$137) | May 20, 2026 | Pre-scheduled 10b5-1 plan; not discretionary |
Moore Alexander D. | Director | 10b5-1 Planned Sale | 16,000 | ~$2.1M (est. at ~$133) | May 15, 2026 | Recurring monthly 10b5-1 sale; consistent with prior months |
Assessment: Nothing stands out. All 9 transactions since the Q1 print are pre-scheduled 10b5-1 planned sales — the most routine form of insider selling. Director Moore’s recurring 16,000-share monthly sales are particularly mechanical. The absence of any discretionary open-market buying or selling, and the absence of any 10b5-1 plan initiations or terminations, means the insider signal is neutral heading into Q2 earnings.
This document is prepared for informational purposes only and does not constitute investment advice. All consensus estimates are sourced from Visible Alpha as of August 2, 2026. Past beat/miss history is not indicative of future results. Prepared: August 2, 2026.